Off-target benefits of influenza vaccination in cardiovascular disease

Key Points

• The aim is to explore the cardiovascular benefits of influenza vaccination beyond its primary purpose.
• Randomized trial design with cardiovascular disease patients.
• Assessments of immune response and inflammatory markers pre- and post-vaccination.
• Statistical analyses of health outcomes related to vaccination.
• A significant reduction in heart attack rates post-vaccination (OR 0.65, 95% CI 0.49-0.87, p=0.003).
• Inflammatory markers decreased significantly in vaccinated individuals (p<0.05).
• Improvement in overall cardiovascular health metrics observed in the vaccination group.